Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
The Journal of the Association of Physicians of India|July 3, 2020
Infections in Systemic Lupus ErythematosusAnjali G Rajadhyaksha, Kunal JobanputraIndian Journal of Cancer|May 16, 2025
Cytomegalovirus infection in non-Hodgkin lymphoma: A case seriesKunal Jobanputra, Rahul Ravind, Yashwant Kashyap, et al.NPJ Breast Cancer|August 16, 2025
Bridging the gap: ctDNA, genomics, and equity in breast cancer careJulia Aronson, Manasa Bhatta, Lisa A Carey, et al.Ecancermedicalscience|February 25, 2022
Efficacy and safety of neoadjuvant chemotherapy (NACT) with paclitaxel plus carboplatin and oral metronomic chemotherapy (OMCT) in patients with technically unresectable oral squamous cell carcinoma (OSCC)Lakhan Kashyap, Vijay Patil, Vanita Noronha, et al.Clinical Lymphoma, Myeloma & Leukemia|July 9, 2022
"Diffuse Large B-Cell Lymphoma in the Elderly: Real-World Outcomes From a Developing Country"Kunal Jobanputra, Lingaraj Nayak, Hasmukh Jain, et al.Ecancermedicalscience|January 21, 2026
Is active surveillance a good treatment option for stage 1 seminoma in a developing nation? Long-term outcomes from the Indian subcontinentAditya Dhanawat, Debdeep Samaddar, Bhagyashri Jadhav, et al.Ecancermedicalscience|July 3, 2025
Clinical profile and outcomes of young women with denovo-metastatic breast cancer: real-world data from a tertiary care centre in IndiaSushmita Rath, Mehak Trikha, Laboni Sarkar, et al.South Asian Journal of Cancer|December 31, 2025
Real-World Experience of First-Line Osimertinib in EGFR Mutated Non-Small Cell Lung Cancers from a Tertiary Cancer Center, IndiaAtul Tiwari, Ajay Kumar Singh, Vanita Noronha, et al.JCO Global Oncology|July 9, 2026
Prognostic Reclassification and Survival Outcomes in Intermediate-Risk and Poor-Risk Nonseminomatous Germ Cell Tumors: Single-Institution Experience From Western IndiaKunal Jobanputra, Aditya Dhanawat, Gagan Prakash, et al.Medical Oncology (Northwood, London, England)|December 22, 2023
Repurposing pantoprazole in combination with systemic therapy in advanced head and neck squamous cell carcinoma: a phase I/II randomized studyVanita Noronha, Vijay Patil, Nandini Menon, et al.Pageof 2